Healthcare costs


Paying for diabetes

“He who has health, has hope. And he who has hope, has everything.” (Arabic Proverb)

Estimating the national and global costs of diabetes

This article sets out to do a number of things. First, it will revisit the rationale and methods of estimating the national and global costs of diabetes as included in the early editions of IDF’s Atlas. It will also comment on the ways in which these methods have developed in more recent editions and outline a number of potential misinterpretations of disease-specific cost data.

Cost-effective and cost-saving interventions for prevention and control of diabetes

Diabetes imposes large economic burdens on national healthcare systems across the world. In 2015, the International Diabetes Federation (IDF) estimated that 415 million adults aged 20 to 79 years had diabetes and USD 673 billion was spent to treat diabetes and its related complications. This accounted for 11.6% of the total health expenditure worldwide.

Insulin in 2016: challenge and constraints to access

Insulin was discovered in 1921, first used by an individual with type 1 diabetes in 1922 and then became widely available in the “Western world”. Challenges of access to insulin have been documented and these relate mainly to issues of availability, price and affordability, particularly in low- and middle-income countries.

Diabetes in the young, school performance and KiDS

School is a vital part of life for children, who spend up to a third of their time in varying educational institutions from the age of 4 to 5 years through to young adulthood.

How does the cost of diabetes affect me and my family?

People with diabetes incur medical costs that can range anywhere from 2 to 5 times greater than people living without diabetes. The extent to which they have to bear these costs or a proportion of them themselves will depend upon the health system where they live and receive care.

W.A.S.H. away the world’s dietary salt

The world’s current dietary salt consumption, more than twice the daily amount recommended, is rubbing the wound of declining public health. Increasing evidence suggests that a high salt intake may directly increase the risk of heart disease, stroke, obesity through soft drink consumption, and many other preventable diseases, including cancers. Restricting dietary salt is even more critical for high-risk populations, such as diabetes.

The untold burden of the non-communicable disease epidemic

The recent Global Risks 2010 report issued by the World Economic Forum identifies chronic non-communicable diseases (NCDs) as one of the most important threats to the world’s agenda and a severe risk for global economic loss. NCDs, including diabetes, cardiovascular and respiratory diseases and cancer, are already extraordinarily costly to governments and the private sector, crowding out essential monies for needed government services and reducing profits.

Developing a global framework to address non-communicable diseases

Heart disease, stroke, diabetes and cancer are now among the leading causes of death and disability around the world. The causes of these diseases include modifiable lifestyle-related risk factors, such as smoking, poor diet, lack of physical activity, as well as non-modifiable risk factors, including age and genetics. Due to population growth and the relative success of efforts to reduce communicable diseases, the number of people with non-communicable diseases will continue to rise in the future.

The economics of chronic disease: the case for government intervention

Much is heard of late about the high costs of chronic diseases like diabetes: chronic diseases are going to ‘break the bank’, impose tremendous costs on already struggling healthcare systems, and, very possibly, hinder growth in developing countries. Often, however, the suffering of people with chronic diseases seems to be lost in all the talk of money.